These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12881088)

  • 1. Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy.
    Castelo-Branco C; Blumel JE; Araya H; Riquelme R; Castro G; Haya J; Gramegna G
    J Obstet Gynaecol; 2003 Jul; 23(4):426-30. PubMed ID: 12881088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of sexual dysfunction in climacteric women. Influence of menopause and hormone replace therapy].
    Blümel JE; Araya H; Riquelme R; Castro G; Sánchez F; Gramegna G
    Rev Med Chil; 2002 Oct; 130(10):1131-8. PubMed ID: 12491830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Espinoza MT; Flores D; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Vallejo S; Tserotas K;
    Menopause; 2009; 16(6):1139-48. PubMed ID: 19458559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of sexuality among middle-aged women using the Female Sexual Function Index.
    Chedraui P; Perez-Lopez FR; San Miguel G; Avila C
    Climacteric; 2009 Jun; 12(3):213-21. PubMed ID: 19117186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sexual function in postmenopausal women using hormone replacement therapy].
    Blumel JE; Bravo F; Recavarren M; Sarrá S
    Rev Med Chil; 2003 Nov; 131(11):1251-5. PubMed ID: 14743685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual dysfunction and related risk factors in a cohort of middle-aged Ecuadorian women.
    Yánez D; Castelo-Branco C; Hidalgo LA; Chedraui PA
    J Obstet Gynaecol; 2006 Oct; 26(7):682-6. PubMed ID: 17071440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones and sexuality during transition to menopause.
    Gracia CR; Freeman EW; Sammel MD; Lin H; Mogul M
    Obstet Gynecol; 2007 Apr; 109(4):831-40. PubMed ID: 17400843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of sexual activity in middle-aged women in Chile.
    Blümel JE; Castelo-Branco C; Cancelo MJ; Romero H; Aprikian D; Sarrá S
    Menopause; 2004; 11(1):78-81. PubMed ID: 14716186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors.
    Safarinejad MR
    Int J Impot Res; 2006; 18(4):382-95. PubMed ID: 16395324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual function, menopause and hormone replacement therapy (HRT).
    González M; Viáfara G; Caba F; Molina E
    Maturitas; 2004 Aug; 48(4):411-20. PubMed ID: 15283933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hypoactive sexual desire disorder and associated factors in a cohort of oophorectomized women.
    Castelo-Branco C; Palacios S; Combalia J; Ferrer M; Traveria G
    Climacteric; 2009 Dec; 12(6):525-32. PubMed ID: 19905904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life prevalence of hormone replacement therapy and profile of users have not changed among women with self-reported menopause in the last two decades in Porto, Portugal.
    Lucas R; Barros H
    Climacteric; 2008 Feb; 11(1):26-31. PubMed ID: 18202962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual functioning in postmenopausal women not taking hormone therapy in the Gynecological and Menopause Clinic, Songklanagarind Hospital measured by Female Sexual Function Index questionnaire.
    Peeyananjarassri K; Liabsuetrakul T; Soonthornpun K; Choobun T; Manopsilp P
    J Med Assoc Thai; 2008 May; 91(5):625-32. PubMed ID: 18672623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between sexual function and depression in sexually active, mid-aged, Peruvian women.
    Mezones-Holguin E; Córdova-Marcelo W; Lau-Chu-Fon F; Aguilar-Silva C; Morales-Cabrera J; Bolaños-Díaz R; Pérez-López FR; Chedraui P
    Climacteric; 2011 Dec; 14(6):654-60. PubMed ID: 21961836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.